This study aimed to evaluate the importance of vaccination against Newcastle Disease (ND) in budgerigars (Melopsittacus undulatus) and to investigate the state of carrier of the virus (NDV) in this species. There were used 72 budgerigars distributed into four different experimental groups, vaccinated or not against ND: GI (Ulster 2C strain), GII (B1 strain), GIII (LaSota strain) and GIV (not vaccinated-control). At 11 months of age, all groups of birds were challenged with a pathogenic virus (NDV) suspension, EID50 = 10 /0.1 mL.
INTRODUCTION
Budgerigars also known as the common pet parakeet (Melopsittacus undulatus Shaw, 1805, Psittaciformes: Psittacidae) is widely acknowledged as the most
MATERIALS AND METHODS
common pet parrot in the world. They are intelligent and Experimental birds and management: A total number of social birds and its natural habitat is in Australia 72 (5 month-old) budgerigars were distributed in a (Lendon, 1973) . Newcastle Disease (ND) is caused by completely randomized experimental design with four Avian Parainfluenzavirus serotype 1 (APMV-1/NDV) different treatments, with three replicates of six birds viruses which is a member of the genus Avulavirus, of each. Birds were allocated in experimental cages, the Paramyxoviridae family (ICTV, 2010). The disease is receiving water ad libitum. The diet comprised fresh world-wide distributed in a large range of hosts. Natural fruits, seeds, vegetables and vitamin supplements. or experimental infection with ND virus has been demonstrated in at least 241 species from 27 of the 50
Vaccines: Birds were designated to treatments, orders of birds (Kaleta and Baldauf, 1988; Spradbrow, according to vaccination strain as GI (Ulster 2C), GII 1988). Psittaciformes are highly susceptible to the (B1), GIII (LaSota) and GIV (control-not vaccinated). Newcastle Disease Virus (NDV) (Erickson, 1977) .
Commercial live NDV vaccines (Ulster 2C, B1 and However, there is little information available regarding LaSota strains) were administered to each experimental health programs in this species. Because these birds group, as described by Paulillo et al. (1996) . All birds, are commonly kept as a pet in captivity, they might be except those in the control group, were vaccinated, by important NDV carriers. Thus, this study aimed t o eye drop, at 5 months of age and revaccinated at, 7, 8.5 evaluate the importance of vaccination against ND in this and 10 months of age with the same vaccine strain that species and also to investigate the state of NDV carrier of budgerigars.
was applied in the first vaccination. Vaccine titers were region of the NDV genome, described by Toyoda (1989) . obtained by determining 50% (EID50) of the embryo-P1F (foward) 5'-TTG ATG GCA GGC CTC TTG C-3' and infecting dose in embryonated eggs SPF chickens was P2R (reverse) 5'-GGA GGA TGT TGG CAG CAT Y-3'. 10 /0.1mL = ED50 (Ulster 2C); 10 /0.1mL = ED50 (B1) 7.15 7.20 and 10 /0.1mL = ED50 (LaSota).
7.35
Challenge: At 11 months of age, two budgerigars from each repetition (six per treatment) were challenge with viscerotropic DN virus strain pathogenic for chickens. The virus had intra-cerebral pathogenic index of 1.78 and embryonic death time of 48h, with title of EID50 = 8.15 log10/0.1 mL. Two hundred microliters of the suspension of the virus were administered by oculonasal rout, according to the Code of Federal Regulations (1993) . In order to measure the pathogenicity of the NDV challenge strain, a group of Specific-Pathogen-Free (SPF) chickens of 30 days old were used. The birds were housed in negative pressure isolators with filtered air and offered food and water ad libitum.
Serology: Blood samples of all budgerigars were collected 13 and 19 days post challenge with NDV. Sera samples were submitted to inhibition o f hemagglutination (HI) test, according to Cunningham (1971) .
Viral genome excretion:
At 13 and 19 days post challenge, RNA extraction from cloacal swabs was performed from all birds of each group to carry out virus (NDV) isolation. They were placed in phosphate buffer solution (pH 7, 2). The NucleoSpin RNA Virus Kit was ® used, according to the manufacturer's protocol. RT-PCR was performed using primers targeting a conserved
RESULTS AND DISCUSSION
Data about the challenge with viscetrotropic velogenic NDV pathogenic in budgerigars are shown in Table 1 . Budgerigars of the control group (G IV) did not demonstrate signs of Newcastle Disease, being refractory to the clinical disease with the NDV, in contrast with the observation of Erickson (1977) , were budgerigars exposed to NDV developed clinical signs such as apathy, inappetence and ruffled feathers after three days to two weeks of exposure. It is possible to suggest that this fact is linked with the recombination phenomenon present in populations and subpopulations of NDV viral particles, reflecting the resistance of budgerigars to ND. On the other hand, in vaccinated budgerigars (Groups I-III), the percentage of protection to the challenge was 100% (Table 1) . Furthermore, 100% of the SPF chickens died due to the NDV challenge, confirming the virus pathogenicity. The results of the genome excretion of NDV velogenic strain in budgerigars after challenge are own in Table 2 . In budgerigars from the control group the genome excretion of the NDV was negative 13 and 19 days after the challenge, by RT-PCR. These results can b e explained due to the intermittent elimination of the NDV. However, antibody titres were detected by the HI test 13 and 19 days after challenge, confirming the susceptibility of this species to the NDV. In contrast, genome excretion of the NDV was not detected by RT-PCR and HI test from vaccinated groups (G I to III) of budgerigars, after 13 and 
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